(Q29031767)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5549492%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Hydroxyprogesterone caproate therapy in advanced endometrial cancer (English)

2 references

https://doi.org/10.1002%2F1097-0142%28197103%2927%3A3%3C485%3A%3AAID-CNCR2820270302%3E3.0.CO%3B2-1

26 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5549492%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

Edward Conrad Reifenstein

1 June 2023

author

1

object named as

E C Reifenstein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5549492%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

language of work or name

English

0 references

publication date

1 March 1971

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5549492%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

number of pages

18

1 reference

based on heuristic

inferred from page(s)

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

1 June 2023

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

1 June 2023

2 references

https://doi.org/10.1002%2F1097-0142%28197103%2927%3A3%3C485%3A%3AAID-CNCR2820270302%3E3.0.CO%3B2-1

26 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5549492%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

27

2 references

https://doi.org/10.1002%2F1097-0142%28197103%2927%3A3%3C485%3A%3AAID-CNCR2820270302%3E3.0.CO%3B2-1

26 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5549492%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

3

2 references

https://doi.org/10.1002%2F1097-0142%28197103%2927%3A3%3C485%3A%3AAID-CNCR2820270302%3E3.0.CO%3B2-1

26 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5549492%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

485-502

2 references

https://doi.org/10.1002%2F1097-0142%28197103%2927%3A3%3C485%3A%3AAID-CNCR2820270302%3E3.0.CO%3B2-1

26 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5549492%20AND%20SRC:MED&resulttype=core&format=json

Progesterone in the Treatment of Advanced Malignant Tumours of Breast, Ovary and Uterus

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197103%2927%3A3%3C485%3A%3AAID-CNCR2820270302%3E3.0.CO%3B2-1

An endocrine basis for endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197103%2927%3A3%3C485%3A%3AAID-CNCR2820270302%3E3.0.CO%3B2-1

MANAGEMENT OF ADVANCED ENDOMETRIAL ADENOCARCINOMA WITH MEDROXYPROGESTERONE ACETATE

21 January 2018

1

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

Alterations in carbohydrate metabolism induced by progesterone in cases of endometrial carcinoma and hyperplasia

1 June 2023

3

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

DISEASE-ORIENTED END RESULTS. A TOOL FOR PATHOLOGICAL-CLINICAL ANALYSIS

1 June 2023

4

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

6-alpha-methyl- 17-alpha-hydroxyprogesterone acetate as a chemotherapeutic agent in adenocarcinoma of the uterus

1 June 2023

6

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

Maximum utilization of the life table method in analyzing survival

1 June 2023

7

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

PROGESTATIONAL DRUGS IN THE MANAGEMENT OF ENDOMETRIAL CANCER

1 June 2023

10

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

17-alpha-hydroxyprogesterone caproate treatment of gynecologic cancer

1 June 2023

15

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

The histological changes produced in untreated adeno-carcinoma of the endometrium by a progestogen

1 June 2023

16

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

Progestational agents in the treatment of carcinoma of the endometrium

1 June 2023

20

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

1 June 2023

21

25

1190

Kelley

1965

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

A Progestogen for Treatment of Advanced Endometrial Cancer

1 June 2023

22

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium

1 June 2023

25

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

Treatment of carcinoma in situ of the endometrium

1 June 2023

26

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

Use of progestational agents in the management of endometrial cancer

1 June 2023

28

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

Progestogen therapy for advanced carcinoma of the endometrium

1 June 2023

29

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

The role of chemotherapy in the treatment of gynecologic malignancy

1 June 2023

31

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

Progestogen treatment of recurrent carcinoma of the endometrium

1 June 2023

32

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

Hormonal treatment of recurrent endometrial carcinoma. Report of a case

1 June 2023

33

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

Treatment of advanced endometrial carcinoma with a progestational agent.

1 June 2023

34

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

Progestins in the treatment of patients with endometrial adenocarcinoma

1 June 2023

40

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

HISTOLOGICAL EFFECTS OF PROGESTINS ON HYPERPLASIA AND CARCINOMA IN SITU OF THE ENDOMETRIUM--FURTHER OBSERVATIONS

1 June 2023

42

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

DAY-TO-DAY VARIATION IN LH EXCRETION IN CARCINOMA OF THE ENDOMETRIUM AND NORMAL MENOPAUSE.

1 June 2023

50

1 reference

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

https://api.crossref.org/works/10.1002/1097-0142(197103)27:3%3C485::AID-CNCR2820270302%3E3.0.CO;2-1

1 June 2023

Identifiers

10.1002/1097-0142(197103)27:3<485::AID-CNCR2820270302>3.0.CO;2-1

2 references

https://doi.org/10.1002%2F1097-0142%28197103%2927%3A3%3C485%3A%3AAID-CNCR2820270302%3E3.0.CO%3B2-1

26 March 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:5549492%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference